Lv0
0 积分 2025-12-25 加入
DS‐8201a, a new HER2‐targeting antibody–drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2‐positive gastric cancer T‐DM1 resistance
9个月前
已完结
Assessing ADC Plasma Stability by LC-MS Methods
9个月前
已完结
Pharmacology and pharmacokinetics of antibody-drug conjugates, where do we stand?
10个月前
已完结
Dual-payload antibody–drug conjugates: Taking a dual shot
10个月前
已完结